scPharmaceuticals Inc. (SCPH) Social Stream



scPharmaceuticals Inc. (SCPH): $4.51

0.09 (+2.04%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

SCPHARMACEUTICALS INC (SCPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SCPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-16 3 $15 $6 $10.666 $6.28 69.84%
2022-03-23 3 $15 $5 $10.333 $6.28 64.54%
2022-05-17 2 $15 $6 $10.5 $6.28 67.2%
2022-10-03 3 $15 $6 $10.333 $6.28 64.54%
2022-10-14 3 $15 $11 $13 $6.28 107.01%
2022-10-28 4 $15 $11 $13.25 $6.28 110.99%
2022-11-28 4 $18 $12 $14.25 $6.28 126.91%
2022-12-02 5 $25 $12 $16.4 $6.28 161.15%
2023-02-22 5 $25 $13 $16.6 $6.28 164.33%
2023-03-23 5 $18 $13 $14.75 $6.28 134.87%
2023-03-24 5 $25 $13 $16.8 $6.28 167.52%
2023-04-24 5 $25.001 $13 $16.8 $6.28 167.52%
2023-05-11 5 $25.001 $13 $17.4 $6.28 177.07%
2023-05-15 5 $25 $14 $18.8 $6.28 199.36%
2023-08-14 5 $25 $16 $19.2 $6.28 205.73%
2023-11-13 6 $25 $16 $19.333 $6.28 207.85%

The Trend in the Analyst Price Target


SCPH's average price target has moved up $5.08 over the prior 12 months.

SCPH reports an average of 125.56% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-24 5 25.001 13 16.8 10.16 65.35%
2023-05-02 5 25.001 13 17.4 10.58 64.46%
2023-05-11 5 25.001 13 17.4 11.20 55.36%
2023-05-15 5 25.000 14 18.8 11.53 63.05%
2023-07-19 5 25.000 16 19.2 8.35 129.94%

SCPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 13 months, SCPH's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SCPHARMACEUTICALS INC's number of analysts covering the stock is higher than 284.6% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, SCPHARMACEUTICALS INC's average analyst price target is greater than 336.65% of them.
  • In terms of how SCPHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1613.74% of that group.
  • In the context of stocks in the small market cap category, SCPHARMACEUTICALS INC's variance in analysts' estimates is lower than -1218.93% of them.

In the Pharmaceutical Products industry, KALA, ATHE, and VRNA are the three stocks most similar to SCPHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is SCPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!